Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum WELL Health Technologies Corp T.WELL

Alternate Symbol(s):  T.WELL.DB | WHTCF

Healthcare
WELL Health Technologies Corp. is a practitioner-focused digital healthcare company. The Company develops technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. Its business units include Canadian Patient Services, WELL Health USA Patient Services and SaaS and Technology Services. WELL Health USA Patient and... see more

TSX:WELL - Post Discussion

WELL Health Technologies Corp > Stockchase Insights
View:
Post by retiredcf on Mar 21, 2023 9:27am

Stockchase Insights

From yesterday. GLTA

BUY
WELL Health Technologies(WELL-T)
20/03/2023
 
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research.
2024  Expectations :
 
Q4 EPS 3.7c; revenue $146.1M. 
2022 EPS 12c; revenue $538.5M
2023 EPS 21c; revenue $621M
We would consider it a buy today. 
 
Healthcare
 
Stockchase Insights
$4.100
 
Comment by retiredcf on Mar 21, 2023 9:43am
Initial reaction. GLTA Adj. EPS of $0.05 beat estimates of $0.037; revenue rose 35% to $156M and beat estimates by 7%. Margins of 51.3% did miss estimates of 53.3%. 2023 revenue guidance was nicely increased, to $665M+ from estimates of $621M. This does not include potential acquisitions. This is 17%+ growth and forecasted EBITDA growth is 10%+. Commentary sounded quite positive but the conf ...more  
WELL Health Technologies Corp
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities